Spark Therapeutics

Business

The $850K, Philly-Developed Blindness Treatment That Could Be the Gateway to Curing Big Disease

Last month, the U.S. Food and Drug Administration (FDA) announced its approval of Spark Therapeutics’ Luxturna, a one-time treatment for adults and children with a […]

Business

Spark Therapeutics Gene Therapy for Blindness Moves Forward With FDA

There’s a greater chance now than ever before that the Food and Drug Administration‘s first two approved gene therapies will both come from Philadelphia. This week, […]